238 related articles for article (PubMed ID: 19777440)
1. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.
Tevz G; Kranjc S; Cemazar M; Kamensek U; Coer A; Krzan M; Vidic S; Pavlin D; Sersa G
J Gene Med; 2009 Dec; 11(12):1125-37. PubMed ID: 19777440
[TBL] [Abstract][Full Text] [Related]
2. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
[TBL] [Abstract][Full Text] [Related]
3. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread.
Cichoń T; Jamrozy L; Glogowska J; Missol-Kolka E; Szala S
Cancer Gene Ther; 2002 Sep; 9(9):771-7. PubMed ID: 12189527
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.
Hanna E; Zhang X; Woodlis J; Breau R; Suen J; Li S
Cancer Gene Ther; 2001 Mar; 8(3):151-7. PubMed ID: 11332985
[TBL] [Abstract][Full Text] [Related]
5. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
6. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis.
Saidenberg-Kermanac'h N; Bessis N; Deleuze V; Bloquel C; Bureau M; Scherman D; Boissier MC
J Gene Med; 2003 Feb; 5(2):164-71. PubMed ID: 12539154
[TBL] [Abstract][Full Text] [Related]
8. Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor.
Agah R; Malloy B; Sherrod A; Bean P; Girgis E; Mazumder A
J Biol Response Mod; 1988 Apr; 7(2):140-51. PubMed ID: 3258905
[TBL] [Abstract][Full Text] [Related]
9. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation.
Zhu S; Li S
Methods Mol Biol; 2008; 423():327-37. PubMed ID: 18370211
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer.
Kreiss P; Bettan M; Crouzet J; Scherman D
J Gene Med; 1999; 1(4):245-50. PubMed ID: 10738557
[TBL] [Abstract][Full Text] [Related]
11. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.
Worth LL; Jia SF; Zhou Z; Chen L; Kleinerman ES
Clin Cancer Res; 2000 Sep; 6(9):3713-8. PubMed ID: 10999765
[TBL] [Abstract][Full Text] [Related]
12. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
Cao X; Wang Q; Ju DW; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
[TBL] [Abstract][Full Text] [Related]
13. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.
Pappo I; Tahara H; Robbins PD; Gately MK; Wolf SF; Barnea A; Lotze MT
J Surg Res; 1995 Feb; 58(2):218-26. PubMed ID: 7861776
[TBL] [Abstract][Full Text] [Related]
14. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment.
Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
J Control Release; 2005 Jan; 101(1-3):273-85. PubMed ID: 15588911
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
Berman RM; Suzuki T; Tahara H; Robbins PD; Narula SK; Lotze MT
J Immunol; 1996 Jul; 157(1):231-8. PubMed ID: 8683120
[TBL] [Abstract][Full Text] [Related]
16. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
Nastala CL; Edington HD; McKinney TG; Tahara H; Nalesnik MA; Brunda MJ; Gately MK; Wolf SF; Schreiber RD; Storkus WJ
J Immunol; 1994 Aug; 153(4):1697-706. PubMed ID: 7913943
[TBL] [Abstract][Full Text] [Related]
17. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
Tahara H; Zitvogel L; Storkus WJ; Zeh HJ; McKinney TG; Schreiber RD; Gubler U; Robbins PD; Lotze MT
J Immunol; 1995 Jun; 154(12):6466-74. PubMed ID: 7759882
[TBL] [Abstract][Full Text] [Related]
18. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.
Magnon C; Opolon P; Connault E; Mir LM; Perricaudet M; Martel-Renoir D
Gene Ther; 2008 Nov; 15(21):1436-45. PubMed ID: 18548116
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor effect of interleukin-2 gene-transfected tumor vaccine in combination with interleukin-6 gene-transfected tumor vaccine].
Cao X; Zhang W; Tao Q
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):602-5, 639. PubMed ID: 8697075
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.
Dezso B; Haas GP; Hamzavi F; Kim S; Montecillo EJ; Benson PD; Pontes JE; Maughan RL; Hillman GG
Clin Cancer Res; 1996 Sep; 2(9):1543-52. PubMed ID: 9816331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
